Evidence map›Paper›PMID 40265260›Full record

Trial reportPain practice : the official journal of World Institute of Pain2025

Paddle leads for the treatment of nonsurgical back pain-The DISTINCT study.

Steven Falowski, Michael J Dorsi, Robert Heros, Rafe Sales, Edward Tavel, Todd Lansford, Martin E Weinand, Nrupen Baxi, Jason Garber, James Forage and 13 more

Abstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in Pain practice : the official journal of World Institute of Pain, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Paddle leads for the treatment of nonsurgical back pain-The DISTINCT study.Pain practice : the official journal of World Institute of Pain · 2025
    Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Steven FalowskiNeurosurgical Associates of Lancaster, Lancaster, Pennsylvania, USA.ORCID https://orcid.org/0000-0003-3996-087X
Michael J DorsiNeurosurgery, University of California Los Angeles, Los Angeles, California, USA.
Robert HerosSpinal Diagnostics, Tualatin, Oregon, USA.ORCID https://orcid.org/0000-0001-6800-4372
Rafe SalesSummit Spine Institute, Portland, Oregon, USA.
Edward TavelClinical Trials of South Carolina, Charleston, South Carolina, USA.
Todd LansfordSouth Carolina Sports Medicine and Orthopaedic Center, Charleston, South Carolina, USA.
Martin E WeinandBanner University Medical Center, Tucson, Arizona, USA.
Nrupen BaxiDepartment of Neurosurgery, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York, USA.
Jason GarberLVNI, Center for spine and brain Surgery, Las Vegas, Nevada, USA.
James ForageThe Spine and Brain Institute, Nevada, USA.
Albert E TelfeianDepartment of Neurosurgery, Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.
Haddad SouheilSaint Louis Pain Consultants, Creve Coeur, Missouri, USA.
Christopher GilliganBrigham & Women's Hospital, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0003-4769-9907
Timothy DeerThe Spine and Nerve Center of the Virginias, Charleston, West Virginia, USA.ORCID https://orcid.org/0000-0001-8907-7730
Robert LevyAnesthesia Pain Care Consultants, Tamarac, Florida, USA.
Jessica JamesonAxis Spine Center, Post Falls, Idaho, USA.
Susan MoeschlerDepartment of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Jonathan DuncanBurkhart Research Institute for Orthopaedics, San Antonio, TX, USA.
Chi LimCarolina Orthopaedic & Neurosurgical Associates, Spartanburg, South Carolina, USA.
Mehul DesaiInternational Spine, Pain & Performance Center, Washington, DC, USA.ORCID https://orcid.org/0000-0001-6870-9436
Julie PilitsisDepartment of Neurosurgery, University of Arizona, Tucson, Arizona, USA.
Udoka OkaroAbbott Labs, Austin, Texas, USA.ORCID https://orcid.org/0000-0001-8762-5959
James YueFrank H. Netter School of Medicine, Quinnipiac University, Connecticut Orthopaedics, Hamden, Connecticut, USA.

Funding

Abbott Laboratories
6 · The paper itself

Abstract

introductionDISTINCT is a randomized controlled trial evaluating passive recharge burst SCS compared with CMM in improving pain and pain-related physical function in patients suffering from chronic back pain without prior lumbar surgery, and for whom corrective surgery is not an option. Sub-analyses of outcome measures are presented for a subset implanted with paddle leads at both 6 and 12 months.

objectiveTo investigate the treatment effect of using BurstDR-capable SCS in nonsurgical low back pain (NSLBP) patients with paddle leads.

methodsAn independent board-certified spine surgeon reviewed each case, confirming a lack of corrective surgical options. Out of 29 sites and 115 implants, 10 sites implanted 50 patients with paddle leads. Primary and secondary endpoints assessed improvements in low back pain intensity (NRS), low back pain-related disability (ODI), pain catastrophizing (PCS), and patient global impression of change (PGIC).

resultsData for patients with NSLBP and implanted with paddle leads are available for 47 and 44 patients at 6 and 12 months, respectively. Patients reported significant reductions in pain relief at 6 and 12 months, decreasing from 7.8 ± 1.2 at baseline to 2.0 ± 1.6 and 2.2 ± 2.2, respectively (p < 0.0001). Disability was substantially reduced (> 20 points) from severe to mild at 6 and 12 months; ODI reduced from 54.4 ± 15.0 at baseline to 19.9 ± 14.1 and 22.1 ± 13.6, respectively (p < 0.0001). Pain catastrophizing improved to reflect the average of a non-chronic pain population; decreased from 27.6 ± 13.1 at baseline to 8.1 ± 8.2 and 7.8 ± 9.9 (p < 0.0001). 93.2% of patients reported a moderately better-much-improved outcome on PGIC. Ten complications occurred in 9 patients, 3 being severe device-related events. Two explants were required; one due to infection and one due to persistent pain at the IPG site, and one lead-related event was resolved by surgical repositioning.

conclusionsPassive recharge burst using paddle leads provides substantial relief to patients suffering from severe, debilitating, NSLBP. Patients report significant improvements in pain, function, and pain-related emotional distress. In addition, the rate of adverse events is low, supporting a favorable safety profile.

Indexed as

Electrodes, ImplantedLow Back PainAdultAgedChronic PainFemaleHumansMaleMiddle AgedPain MeasurementTreatment Outcomelow back painspinal cord stimulation

Identifiers

PMID40265260
PMCPMC12015649

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.